8-K - Onconetix, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry Into a Material Definitive Agreement On December 6, 2025, Proteomedix AG, a Swiss Company (“Proteomedix”), a wholly-owned subsiairy of Onconetix, Inc. (

Material Agreement

$300.0K

Source Document

9.01

Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed or furnished, as applicable, with this Current Report on Form 8-K: Exhibi

Exhibits Only

Exhibits (2)

10.1

FIRST AMENDMENT TO LICENSE AGREEMENT BETWEEN PROTEOMEDIX AG AND LABORATORY CORPORATION OF AMERICA HOLDINGS, DATED DECEMBER 6, 2025

8-K

CURRENT REPORT